Microbiome Insights is a high growth, revenue-stage company that has established itself as a global leader in the microbiome testing market. The company has developed a microbiome-based chronic disease management platform and is launching its first proprietary product to help IBD patients manage their disease. This test will also be marketed to pharma as clinical development biomarker for IBD drug development. Annual revue over $1 million.
iTag Amplicon Sequencing
WHO’S THERE?
Analysis of composition of microbial communities for prokaryotic communities (16S V4), eukaryotic communities (18S), fungal communities (ITS2), and archaeal communities (16S V4-V5), and V4_Skin.
Shotgun Metagenomics
WHAT CAN THEY DO?
Analysis of community composition and functional analysis. Based on high-throughput sequencing and analysis of total DNA.
Quantitative PCR
HOW MANY ARE THERE?
Quantitation of total microbial density or specific microbial populations. Targets total prokaryotes, bacteria, archaea, fungi and other taxonomic or functional groups by request.
Short Chain Fatty Acids
Quantitation of faecal Short Chain Fatty Acids to monitor gut health and inflammation. Based on analysis in a gas chromatograph (GC) coupled with a flame ionization detector (FID).
Calprotectin
Quantification of faecal calprotectin as an indicator of intestinal inflammation. Based on a high specificity immunochemical test.
Custom Analysis
What else can we help you with?
See Website >>